#1254861
Fisher Scientific #0017

Toxicology Reagent DRI® Amphetamines (AMP) CLIA Non-Waived For Automated Clinical Analyzers

Name: Toxicology Reagent
Brand: DRI®

REAGENT, IMMUNOASSAY DRI AMPHETAMINE 100ML D/S

No Image

Compare

Product Specifications

McKesson #

1254861

Manufacturer #

0017

Brand

DRI®

Manufacturer

Fisher Scientific

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Automated Clinical Analyzers

Form

Ready-to-Use Liquid

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogeneous Enzyme Immunoassay (HEIA)

Test Name

Amphetamines (AMP)

Test Type

Single Drug

UNSPSC Code

41116007

Volume

100 mL

Features

The DRI® Amphetamines assay is intended for the qualitative or semi-quantitative determination of amphetamine and methamphetamine in human urine
The assay provides a simple and rapid analytical screening procedure for detecting amphetamine and methamphetamine in urine on automated clinical analyzers
These assays have been field-tested on a wide range of analyzers
Qualitative or semi-quantitative options for results
Excellent correlation to GC/MS